1 asset in Malignant Histiocytosis
Therapeutic assets addressing Malignant Histiocytosis, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
q702 Malignant Histiocytosis | Mayo Clinic | P1 | CC (43) |
Therapeutic assets addressing Malignant Histiocytosis, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
q702 Malignant Histiocytosis | Mayo Clinic | P1 | CC (43) |